Abstract
Benefit of Pegylated Interferon-α-2a/Ribavirin in a Patient with Common Variable Immunodeficiency and Hepatitis C Virus Cirrhosis after Liver Transplantation and Splenic Embolization
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
